- Price
- $254.93
- Day
- +0.20%
- Mkt Cap
- $614.36B
- 52W Range
- $169.65 – $274.90
- Volume
- 7.26M
- Beta
- 0.23
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
First National Bank of Mount Dora Trust Investment Services Sells 2,499 Shares of Johnson & Johnson $JNJ
First National Bank of Mount Dora Trust Investment Services decreased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 25.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,274 shares of the company's stock after selling
Johnson & Johnson $JNJ Shares Sold by FAS Wealth Partners Inc.
FAS Wealth Partners Inc. cut its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 9.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 39,643 shares of the company's stock after selling 4,176 shares during the period. FAS Wealth Partners Inc.'s
Johnson & Johnson (JNJ) Discusses FDA Authorization and Market Introduction of OTTAVA Robotic Surgical System Transcript
Johnson & Johnson (JNJ) Discusses FDA Authorization and Market Introduction of OTTAVA Robotic Surgical System Transcript
Is It Worth Investing in Johnson & Johnson (JNJ) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Johnson & Johnson's OTTAVA Robotic Surgery System Targets Long-Term Growth
Johnson & Johnson NYSE: JNJ outlined its commercialization plans for the OTTAVA robotic surgical system after receiving U.S. Food and Drug Administration De Novo authorization, positioning the table-integrated platform as a long-term growth initiative in surgical robotics.